Therapy News and Research

RSS

Genesis inks asset purchase agreement with Revera

Genesis HealthCare, one of the nation's largest providers of post-acute care, today announced that it has signed an asset purchase agreement with Revera Inc., a leading owner, operator and investor in the senior living sector, to acquire 24 of its skilled nursing facilities along with its contract rehabilitation business for $240 million.

15 Jun 2015

Clinical studies confirm safety, efficacy of opicapone in Parkinson’s disease patients

BIAL is presenting 11 research posters at the 19th International Congress of Parkinson's Disease and Movement Disorders (June 14–15, San Diego, CA). These evaluate the safety and efficacy of opicapone (BIA 9-1067), a novel once-daily catechol-O-methyltransferase (COMT) inhibitor for use as adjunctive therapy in levodopa-treated Parkinson’s disease patients with end of dose motor fluctuations.

15 Jun 2015

VENTANA ALK (D5F3) CDx Assay receives FDA approval

Ventana Medical Systems, Inc., a member of the Roche Group, today announced approval of the VENTANA ALK (D5F3) CDx Assay by the US Food and Drug Administration as a companion diagnostic to aid in the identification of patients for Pfizer's FDA approved targeted therapy, XALKORI (crizotinib).

15 Jun 2015

Mesothelioma.us releases new case study that focuses on experimental treatments for mesothelioma

Mesothelioma.us, an educational and authoritative website that offers free and in-depth resources for mesothelioma patients and their families, has just released a new case study that focuses on the experimental treatments for the disease.

15 Jun 2015

NTCELL Phase I/IIa clinical study meets primary endpoint in patients with Parkinson’s disease

Living Cell Technologies Limited today announced results from a Phase I/IIa clinical study of NTCELL, an experimental regenerative cell therapy being studied as a disease-modifying agent in Parkinson’s disease. The study, conducted in four patients in New Zealand, met its primary endpoint of safety, showing NTCELL implantation was well tolerated, with no adverse events considered to be related to NTCELL.

15 Jun 2015

Study shows bacteriophages remain active against P. aeruginosa infection after nebulization

bacteriophage-based antibacterial therapies to treat drug resistant infections, today announced new data demonstrating that bacteriophages remain active against Pseudomonas aeruginosa (P. aeruginosa) after nebulization.

15 Jun 2015

Study explores role of ALK1 protein in breast cancer metastasis

Pietras said that although prognosis for breast cancer is relatively good when detected in its early stages, metastatic disease is the cause of 90 percent of all cancer-related deaths. Therefore, learning more about the metastatic process and finding new cures to inhibit disease spread is at the center of clinical attention.

15 Jun 2015

American Thoracic Society releases recommendations on achieving good quality sleep

The American Thoracic Society has released a policy statement with recommendations for clinicians and the general public on achieving good quality sleep and getting an adequate quantity of sleep.

15 Jun 2015

Study shows that TNFi dose reduction strategy can help in optimal management of RA

The results of a study presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) showed that, in rheumatoid arthritis (RA) patients, a good clinical response to maintenance treatment with a tumour necrosis factor inhibitor (TNFi) was maintained even when the dose was reduced by one-third.

15 Jun 2015

Spending more time in intensive physical therapy program may benefit stroke survivors

Time may heal all wounds, but in the case of stroke survivors, the key to better recovery is to spend more time in an intensive physical therapy program, according to a University of Florida Health study.

15 Jun 2015

LMU clinicians reveal mechanism involved in determining lifetime of antibody-producing cells

Clinicians at Ludwig-Maximilians-Universitaet in Munich have elucidated a mechanism involved in determining the lifespan of antibody-producing cells, and identified a promising new biomarker for monitoring autoimmune diseases like multiple sclerosis and lupus erythematosus.

15 Jun 2015

Men who use finasteride to treat benign prostate enlargement experience worsening ED

Men with benign prostate enlargement who used finasteride (also known as proscar and propecia) to treat their condition, experienced worsening erectile dysfunction (ED) that did not resolve with continued treatment. In addition, they experienced a reduction in their testosterone levels leading to hypogonadism (little to no production of sex hormones).

14 Jun 2015

Cognitive behavioral therapy can help patients with severe dental anxiety

Adults who suffer from severe dental anxiety (DA) are often dissatisfied with their appearance. The dissatisfaction may be associated with poorer oral health, depression and anxiety. A doctoral thesis at Sahlgrenska Academy found that cognitive behavioral therapy (CBT) help patients with severe DA.

12 Jun 2015

New therapy for osteoporosis may be in the pipeline

Researchers from The Scripps Research Institute (TSRI), Florida, have reported a novel therapeutic approach that could promote the formation of new bone cells in people suffering from bone loss.

12 Jun 2015

Person-centered approach to physical therapy has positive effect on depression

Exercise has a positive effect on depression - so reveals a dissertation written at the Sahlgrenska Academy. In at study at the Sahlgrenska Academy, the researcher evaluated exercise as add-on therapy to medicating with antidepressants. The study divided 62 individuals with diagnosed clinical depression into three groups, in which two participated in two different types of exercise with a physiotherapist twice a week for 10 weeks while the third, the control group, did not participate in systematic exercise.

12 Jun 2015

Older asthmatic patients treated with inhaled corticosteroids at increased risk for treatment failure

Older patients with asthma are at increased risk for treatment failure, particularly those patients being treated with inhaled corticosteroids, according to a new study.

12 Jun 2015

Study examines link between environmental characteristics and apathy in nursing home residents with dementia

Nursing home residents with dementia are less likely to be apathetic if they live in an appropriately stimulating environment, according to nursing researchers.

12 Jun 2015

New noninvasive brain stimulator may help tamp down Parkinson's symptoms at home

Parkinson's disease patients whose symptoms such as tremor, muscle stiffness and slowed movement make it tough to hold an eating utensil steady have few options for relief outside of a hospital or clinic. Medication can help, but over time it tends to become less effective.

12 Jun 2015

Weill Cornell scientists reveal how XBP1 gene can trigger immune responses against ovarian tumors

Ovarian cancer shuts down immune system cells that would otherwise act as a first line of defense against the deadly tumor, Weill Cornell Medical College scientists report today. But a therapy that restores the cells' disease-fighting abilities could provide a powerful new strategy to attack the cancer, which kills more than 14,000 women each year.

12 Jun 2015

Certain ARID1a mutations sensitize some tumors to PARP inhibitor drugs

Mutations in ARID1a, which are common in many cancer types, disrupt DNA damage repair in cancer cells, allowing the cancer to progress. This gene may also be an Achilles' heel when treating certain tumors, according to a team of researchers at The University of Texas MD Anderson Cancer Center.

12 Jun 2015

Therapy News and Research

Genesis inks asset purchase agreement with Revera

Clinical studies confirm safety, efficacy of opicapone in Parkinson’s disease patients

VENTANA ALK (D5F3) CDx Assay receives FDA approval

Mesothelioma.us releases new case study that focuses on experimental treatments for mesothelioma

NTCELL Phase I/IIa clinical study meets primary endpoint in patients with Parkinson’s disease

Study shows bacteriophages remain active against P. aeruginosa infection after nebulization

Study explores role of ALK1 protein in breast cancer metastasis

American Thoracic Society releases recommendations on achieving good quality sleep

Study shows that TNFi dose reduction strategy can help in optimal management of RA

Spending more time in intensive physical therapy program may benefit stroke survivors

LMU clinicians reveal mechanism involved in determining lifetime of antibody-producing cells

Men who use finasteride to treat benign prostate enlargement experience worsening ED

Cognitive behavioral therapy can help patients with severe dental anxiety

New therapy for osteoporosis may be in the pipeline

Person-centered approach to physical therapy has positive effect on depression

Older asthmatic patients treated with inhaled corticosteroids at increased risk for treatment failure

Study examines link between environmental characteristics and apathy in nursing home residents with dementia

New noninvasive brain stimulator may help tamp down Parkinson's symptoms at home

Weill Cornell scientists reveal how XBP1 gene can trigger immune responses against ovarian tumors

Certain ARID1a mutations sensitize some tumors to PARP inhibitor drugs

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News